PDE9A Antikörper
(5 Referenzen)-
- Target Alle PDE9A Antikörper anzeigen
- PDE9A (phosphodiesterase 9A (PDE9A))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PDE9A Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP), Confocal Microscopy (CM), Immunocytochemistry (ICC)
- Aufreinigung
- Affinity Purified
- Immunogen
- Synthetic cyclic peptide common to all PDE9A variants
- Isotyp
- IgG
- Top Product
- Discover our top product PDE9A Primärantikörper
-
anti-phosphodiesterase 9A (PDE9A) (AA 1-533) antibody
PDE9A Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-phosphodiesterase 9A (PDE9A) (N-Term) antibodyPDE9A Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Meerschweinchen, Pferd, Kaninchen, Zebrafisch (Danio rerio) WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-phosphodiesterase 9A (PDE9A) (AA 426-533) antibodyPDE9A Reaktivität: Human ELISA, WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-phosphodiesterase 9A (PDE9A) (N-Term) antibodyPDE9A Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-phosphodiesterase 9A (PDE9A) (AA 434-533) antibodyPDE9A Reaktivität: Human ELISA, WB, IHC (p) Wirt: Maus Monoclonal 1E1 unconjugated
anti-phosphodiesterase 9A (PDE9A) (AA 1-533) antibodyPDE9A Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-phosphodiesterase 9A (PDE9A) (AA 136-185) antibodyPDE9A Reaktivität: Human, Hund WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-phosphodiesterase 9A (PDE9A) antibodyPDE9A Reaktivität: Human, Maus, Ratte, Hund, Affe IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.55 μg/μL
-
-
: "PDE9A is expressed in the inner retina and contributes to the normal shape of the photopic ERG waveform." in: Frontiers in molecular neuroscience, Vol. 7, pp. 60, (2014) (PubMed).
: "Phosphodiesterase type 9 (PDE9) in the human lower urinary tract: an immunohistochemical study." in: BJU international, Vol. 109, Issue 6, pp. 934-40, (2012) (PubMed).
: "PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system." in: Brain research, Vol. 1281, pp. 25-34, (2009) (PubMed).
: "High expression of the cGMP-specific phosphodiesterase, PDE9A, in sickle cell disease (SCD) and the effects of its inhibition in erythroid cells and SCD neutrophils." in: British journal of haematology, Vol. 142, Issue 5, pp. 836-44, (2008) (PubMed).
: "Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation." in: Molecular reproduction and development, Vol. 71, Issue 4, pp. 495-508, (2006) (PubMed).
-
: "PDE9A is expressed in the inner retina and contributes to the normal shape of the photopic ERG waveform." in: Frontiers in molecular neuroscience, Vol. 7, pp. 60, (2014) (PubMed).
-
- Target
- PDE9A (phosphodiesterase 9A (PDE9A))
- Andere Bezeichnung
- PD9A (PDE9A Produkte)
- Synonyme
- PDE9A antikoerper, MGC116558 antikoerper, Pde9a antikoerper, HSPDE9A2 antikoerper, PDE9A1 antikoerper, phosphodiesterase 9A antikoerper, phosphodiesterase 9A S homeolog antikoerper, high affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A antikoerper, PDE9A antikoerper, pde9a.S antikoerper, Pde9a antikoerper, LOC100549810 antikoerper, pde9a antikoerper
- UniProt
- O76083
-
